Skip to primary content
Skip to secondary content

Biotech 365

Main menu

  • Biotech 365
  • Companies
  • Healthcare Investors
    • Healthcare LPs
  • Healthcare Investors Matchmaking
  • Free DEMO
  • Services
    • Preclinical Studies Database
    • Scientific Due Diligence
    • CRO & CDMO Database
  • Contact

Tag Archives: non-integrating strategy

AMSBIO – tissue products

Posted on by

AMSBIO proposes one of the biggest range of tissue products from a single source (RNA, DNA, protein, tissue sections, arrays, etc…). These tools are available from diseased or normal sources.

AMSBIO – tissue products

amsbio Continue reading →

Posted in Biotech Companies, Biotech Companies Germany, Biotech Companies Switzerland, Biotech Companies UK, Biotech Companies USA | Tagged 3-D cell culture, 3D cell culture, adhesion, Alex Sim, AMSBIO, AMSBIO - tissue products, apoptosis, cell culture, cell migration, cellular response DNA damage, CometAssay, CometAssay Electrophoresis System, cytotoxicity, Electrophoresis System, genomics, genotoxicity testing, growing cells 3D, human biomonitoring, human pluripotent stem cell, human pluripotent stem cell culture, human pluripotent stem cells, invasion, magnetic beads, magnetic purification, magnetic silica beads, MEF, MEFs, Mouse Embryonic Fibroblast, Mouse Embryonic Fibroblasts, Newborn Human Foreskin Fibroblast, Newborn Human Foreskin Fibroblasts, non-integrating strategy, NuFF, NuFFs, proliferation, Protein A, Protein G, proteomics, reprogramming stem cell fate, Sandy Allan, SCGE, screening cancer therapeutics, single cell gel electrophoresis, stem cells, Steptavidin, tissue product, tissue products, tissue section, tissue sections

        Services              Healthcare Investors Database              FAQs               CGU               Biotech & Pharma News             Contact
Proudly powered by WordPress